RedHill Biopharma (RDHL) Shares Outstanding (Weighted Average) (2016 - 2025)
Historic Shares Outstanding (Weighted Average) for RedHill Biopharma (RDHL) over the last 14 years, with Q2 2025 value amounting to $18.0 million.
- RedHill Biopharma's Shares Outstanding (Weighted Average) rose 5331.04% to $18.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $18.0 million, marking a year-over-year increase of 5331.04%. This contributed to the annual value of $260000.0 for FY2017, which is 833.33% up from last year.
- Latest data reveals that RedHill Biopharma reported Shares Outstanding (Weighted Average) of $18.0 million as of Q2 2025, which was up 5331.04% from $11.8 million recorded in Q2 2024.
- In the past 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) registered a high of $1.3 billion during Q2 2023, and its lowest value of $11.8 million during Q2 2024.
- Its 5-year average for Shares Outstanding (Weighted Average) is $464.8 million, with a median of $467.4 million in 2021.
- In the last 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) skyrocketed by 13378.95% in 2023 and then tumbled by 9907.97% in 2024.
- RedHill Biopharma's Shares Outstanding (Weighted Average) (Quarter) stood at $467.9 million in 2021, then rose by 16.82% to $546.6 million in 2022, then soared by 133.79% to $1.3 billion in 2023, then tumbled by 99.08% to $11.8 million in 2024, then skyrocketed by 53.31% to $18.0 million in 2025.
- Its last three reported values are $18.0 million in Q2 2025, $11.8 million for Q2 2024, and $1.3 billion during Q2 2023.